Reply to: "Reply to: 'Response to DAA therapy in the NHS England Early Access Programme for rare HCV subtypes from low and middle income countries'"
Epub 2018 Jan 12.
Ana da Silva Filipe
William L Irving
Graham R Foster
Mark A Aldersley
Emma C Thomson
MRC-University of Glasgow Centre for Virus Research, Glasgow, UK.
Gastrointestinal and Liver Disorders Theme, NIHR Nottingham Biomedical Research Centre at the Nottingham University Hospitals NHS Trust and the University of Nottingham, UK.
Blizard Institute, Queen Mary University of London, London, UK.
Institute of Liver Studies, King's College Hospital Foundation Trust, London UK.
Institute of Liver and Digestive Health, University College of London, London, United Kingdom.
Royal Liverpool University NHS Trust, Liverpool, UK.
Liver Unit, St James's University Hospital, Leeds, UK.
Infectious Diseases Unit, University Hospitals Leicester NHS Trust, Leicester, UK.
Infectious Diseases, North Manchester General Hospital, Manchester, UK.
MRC-University of Glasgow Centre for Virus Research, Glasgow, UK. Electronic address: email@example.com.
No abstract available
Research Support, Non-U.S. Gov't
Hepatitis C, Chronic*
MC_UU_12014/1/MRC_/Medical Research Council/United Kingdom
G0801822/MRC_/Medical Research Council/United Kingdom
MR/N005953/1/MRC_/Medical Research Council/United Kingdom
MC_UU_12014/12/MRC_/Medical Research Council/United Kingdom
MC_U130184143/MRC_/Medical Research Council/United Kingdom